ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Telfast 180, überzogene Tabletten - 10
54204002 Opella Healthcare Switzerland AG
Telfast 180, überzogene Tabletten26.06.1997
Original26.06.1997
Fexofenadine (R06AX26)15.11.2006
WHO-DDD 
07.13.10.10
07.13.10. 
D  
Yes 
IPCI
4.34No
    
10 %7.65
7680542040028Synthetika
  
Composition
fexofenadini hydrochloridum 180 mg, cellulosum microcristallinum, amylum pregelificatum, carmellosum natricum conexum corresp. natrium 0.18 mg, magnesii stearas, Überzug: hypromellosum, polyvidonum K 29-32, E 171, silica colloidalis anhydrica, macrogolum 400, E 172 (rubrum), E 172 (flavum), pro compresso obducto.
Packungsbestandteile
überzogene Tabletten 
 
Active AgentDose
Fexofenadine Hydrochloride180 mg
BAG: Active AgentDose
Fexofenadine Hydrochloride180 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Rubrum)  
Amylum Pregelificatum  
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Hypromellosum Überzug
Macrogol400  
Magnesii Stearas  
Polyvidonum K29-32 
Pro Compresso Obducto  
Silica Colloidalis Anhydrica  
 
Source
Data was imported : 05.05.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home